Anthropic’s life science plans; Novartis CEO on China deals; and more
Welcome back to Endpoints Weekly! We’re gearing up for a busy week of earnings coverage, as Moderna, AstraZeneca, GSK, Bristol Myers Squibb and more are set to report their Q2 results. In the meantime, check ...
July 25, 2026 06:00 AM EDT Weekly Anthropic’s life science plans; Novartis CEO on China deals; and more Nicole DeFeudis Senior Reporter Max Gelman Senior Editor Welcome back to Endpoints Weekly! We’re gearing up for a busy week of earnings coverage, as Moderna, AstraZeneca, GSK, Bristol Myers Squibb and more are … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that